FDA Inspection 1192344 — Nippon Sanso Matheson, Inc.

Nippon Sanso Matheson, Inc. — FEI 1627208

The FDA completed an inspection of Nippon Sanso Matheson, Inc. on Dec 9, 2022 in Dallas, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 9, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dallas, TX (United States)

Citations

IDCFRDescription
194221 CFR 211.180(e)Records reviewed annually

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.